These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37046496)

  • 1. Virus-Specific Stem Cell Memory CD8+ T Cells May Indicate a Long-Term Protection against Evolving SARS-CoV-2.
    Aleksova M; Todorova Y; Emilova R; Baymakova M; Yancheva N; Andonova R; Zasheva A; Grifoni A; Weiskopf D; Sette A; Nikolova M
    Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.
    Guo L; Wang G; Wang Y; Zhang Q; Ren L; Gu X; Huang T; Zhong J; Wang Y; Wang X; Huang L; Xu L; Wang C; Chen L; Xiao X; Peng Y; Knight JC; Dong T; Cao B; Wang J
    Lancet Microbe; 2022 May; 3(5):e348-e356. PubMed ID: 35345417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of IFNγ-Secreting CD4
    Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.
    Jung JH; Rha MS; Sa M; Choi HK; Jeon JH; Seok H; Park DW; Park SH; Jeong HW; Choi WS; Shin EC
    Nat Commun; 2021 Jun; 12(1):4043. PubMed ID: 34193870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.
    Channappanavar R; Fett C; Zhao J; Meyerholz DK; Perlman S
    J Virol; 2014 Oct; 88(19):11034-44. PubMed ID: 25056892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
    Lin J; Law R; Korosec CS; Zhou C; Koh WH; Ghaemi MS; Samaan P; Ooi HK; Matveev V; Yue F; Gingras AC; Estacio A; Buchholz M; Cheatley PL; Mohammadi A; Kaul R; Pavinski K; Mubareka S; McGeer AJ; Leis JA; Heffernan JM; Ostrowski M
    J Virol; 2022 Jul; 96(13):e0050922. PubMed ID: 35699447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of CD8
    Lu X; Song B; Weng W; Su B; Wu H; Cheung AKL; Zhang T; Gao Y
    Viral Immunol; 2023 Jan; 36(1):25-32. PubMed ID: 36346310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells with Stem Cell-Like Properties.
    Vigano S; Negron J; Ouyang Z; Rosenberg ES; Walker BD; Lichterfeld M; Yu XG
    J Virol; 2015 Aug; 89(15):7829-40. PubMed ID: 25995260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine.
    Chen Y; Yin S; Tong X; Tao Y; Ni J; Pan J; Li M; Wan Y; Mao M; Xiong Y; Yan X; Yang Y; Huang R; Wu C; Shen H
    Clin Microbiol Infect; 2022 Mar; 28(3):410-418. PubMed ID: 34715346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent memory despite rapid contraction of circulating T Cell responses to SARS-CoV-2 mRNA vaccination.
    Taus E; Hofmann C; Ibarrondo FJ; Gong LS; Hausner MA; Fulcher JA; Krogstad P; Kitchen SG; Ferbas KG; Tobin NH; Rimoin AW; Aldrovandi GM; Yang OO
    Front Immunol; 2023; 14():1100594. PubMed ID: 36860850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients.
    Guerrera G; Mandelli A; Finardi A; Orrico M; D'Orso S; Picozza M; Noviello M; Beretta V; Bonetti B; Calabrese M; Marastoni D; De Rossi N; Capra R; Salvetti M; Buscarinu MC; Inglese M; Uccelli A; Moiola L; Raposo C; Muros-Le Rouzic E; Pedotti R; Filippi M; Bonini C; Battistini L; Borsellino G; Furlan R
    Mult Scler; 2022 Oct; 28(12):1937-1943. PubMed ID: 35723265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines against the original strain of SARS-CoV-2 provide T cell memory to the B.1.1.529 variant.
    Dörnte C; Traska V; Jansen N; Kostyra J; Baurmann H; Lauer G; Huang YJ; Kramer S; Brauns O; Winkels H; Schmitz J; Dose C; Richter A; Schuster M
    Commun Med (Lond); 2022 Nov; 2(1):140. PubMed ID: 36352067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses.
    Balachandran H; Phetsouphanh C; Agapiou D; Adhikari A; Rodrigo C; Hammoud M; Shrestha LB; Keoshkerian E; Gupta M; Turville S; Christ D; King C; Sasson SC; Bartlett A; Grubor-Bauk B; Rawlinson W; Aggarwal A; Stella AO; Klemm V; Mina MM; Post JJ; Hudson B; Gilroy N; Konecny P; Ahlenstiel G; Dwyer DE; Sorrell TC; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA;
    Cell Rep; 2022 Feb; 38(6):110345. PubMed ID: 35090598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses.
    Thiruvengadam R; Awasthi A; Medigeshi G; Bhattacharya S; Mani S; Sivasubbu S; Shrivastava T; Samal S; Rathna Murugesan D; Koundinya Desiraju B; Kshetrapal P; Pandey R; Scaria V; Kumar Malik P; Taneja J; Binayke A; Vohra T; Zaheer A; Rathore D; Ahmad Khan N; Shaman H; Ahmed S; Kumar R; Deshpande S; Subramani C; Wadhwa N; Gupta N; Pandey AK; Bhattacharya J; Agrawal A; Vrati S; Bhatnagar S; Garg PK;
    Lancet Infect Dis; 2022 Apr; 22(4):473-482. PubMed ID: 34838183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel detection of SARS-CoV-2 epitopes reveals dynamic immunodominance profiles of CD8
    van den Dijssel J; Hagen RR; de Jongh R; Steenhuis M; Rispens T; Geerdes DM; Mok JY; Kragten AH; Duurland MC; Verstegen NJ; van Ham SM; van Esch WJ; van Gisbergen KP; Hombrink P; Ten Brinke A; van de Sandt CE
    Clin Transl Immunology; 2022; 11(10):e1423. PubMed ID: 36254196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age related human T cell subset evolution and senescence.
    Li M; Yao D; Zeng X; Kasakovski D; Zhang Y; Chen S; Zha X; Li Y; Xu L
    Immun Ageing; 2019; 16():24. PubMed ID: 31528179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose.
    Belik M; Liedes O; Vara S; Haveri A; Pöysti S; Kolehmainen P; Maljanen S; Huttunen M; Reinholm A; Lundberg R; Skön M; Österlund P; Melin M; Hänninen A; Hurme A; Ivaska L; Tähtinen PA; Lempainen J; Kakkola L; Jalkanen P; Julkunen I
    Front Immunol; 2023; 14():1099246. PubMed ID: 36756112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Circulating T Follicular Helper Cells and Stem-Like Memory CD4
    Ponnan SM; Vidyavijayan KK; Thiruvengadam K; Hilda J N; Mathayan M; Murugavel KG; Hanna LE
    Front Immunol; 2021; 12():666388. PubMed ID: 33936106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific CD8+ memory stem T cells generated from human peripheral blood effectively eradicate allogeneic targets in mice.
    Guan L; Li X; Wei J; Liang Z; Yang J; Weng X; Wu X
    Stem Cell Res Ther; 2018 Dec; 9(1):337. PubMed ID: 30526661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection.
    Moga E; Lynton-Pons E; Domingo P
    Front Immunol; 2022; 13():904686. PubMed ID: 35833134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.